Form D · Other Investment Fund

Contraline Capsule, a series of FundRx Master Fund I, LLC

New York, NY · CIK 0001793999

Offering snapshot reported May 5, 2020 · SEC filing

Reported sold
$290K
Offering amount: $290K
Investors reported
13
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
May 1, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 5, 2020Initial$290,000No comparison13SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C.1
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-366272

Source: Form D, filed May 5, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

CONTRALINE CAPSULE, A SERIES OF FUNDRX MASTER FUND I, LLC

Investment adviser: MBX CAPITAL, LLC

Gross asset value
$280K
Beneficial owners
13
ADV minimum commitment
$5K

Reported in Form ADV on Mar 9, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator FUNDRX CAPITAL MANAGEMENT, LLC WASHINGTON, DC, District of Columbia, United States Investor statements: Yes (provided to all investors) Related to adviser: Yes
Custodian CHOICE FINANCIAL GROUP VIRGINIA BEACH, Virginia, United States Related to adviser: No
Provider details
Annual audit
No
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No
Filing source

Form ADV 2065550 · Mar 9, 2026 · Schedule D 7.B.(1), fund 805-6964453548

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Llc Fund Rx Capital Management, Director
Jeremy Neilson Executive
Richard Thoms Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
43 W 23rd St 6th Floor
New York, NY, 10010